Replimune

Recent news

• BMO Capital Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $16
  Market Newswire · 2026/6/30
• Rating change
  Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $19
  Market Newswire · 2026/8/7
• Company notice
  Frasers Property: REPL-General Announcement-Issue of S$150 Million Fixed Rate Notes Due 2036 By Frasers Property Treasury Pte. Ltd.
  SGX · 2026/8/28
• Rating change
  Cantor Fitzgerald Upgrades Replimune(REPL.US) to Buy Rating
  Market Newswire · 2026/7/31
• Company notice
  AdvancedSystems: REPL-General Announcement-COMMENCEMENT OF LEGAL PROCEEDINGS AGAINST ZICO CAPITAL PTE. LTD. AND APPLICATION FOR INJUNCTION
  SGX · 2026/7/23
• Rating change
  Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $24
  Market Newswire · 2026/8/17
• Rating change
  Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $12
  Market Newswire · 2026/7/31
• Company notice
  AdvancedSystems: REPL-General Announcement-COMMENCEMENT OF LEGAL PROCEEDINGS AGAINST ZICO CAPITAL PTE. LTD. AND APPLICATION FOR INJUNCTION
  SGX · 2026/7/23
• Rating change
  Piper Sandler Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
  Market Newswire · 2026/8/7
• Rating change
  J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20
  Market Newswire · 2026/8/11
• J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21
  Market Newswire · 2026/8/26
• Rating change
  BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16
  Market Newswire · 2026/7/31
• Rating change
  Wedbush Downgrades Replimune(REPL.US) to Hold Rating, Cuts Target Price to $9
  Market Newswire · 2026/7/28
• Rating change
  Leerink Partners Initiates Replimune(REPL.US) With Buy Rating, Announces Target Price $17
  Market Newswire · 2026/8/4
• Company notice
  GuocoLand: REPL-General Announcement-ISSUANCE OF S$110M 2.50% NOTES DUE 2030 UNDER S$3B MMTN PROGRAMME OF GLL IHT PTE. LTD.
  SGX · 2026/6/30
• J.P. Morgan Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $17
  Market Newswire · 2026/6/27
• Company notice
  Sri Trang Gloves: REPL-General Announcement-Reporting Share Repurchase form for Financial Management Purposes No.2 (Revised Date)
  SGX · 2026/9/8
• BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20
  Market Newswire · 2026/8/7
• BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $20
  Market Newswire · 2026/9/11
• Rating change
  Wedbush Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $19
  Market Newswire · 2026/8/17

Headlines are aggregated automatically and are not independently verified or edited by our team.